5Paoletti RD,Casey EW.Reducing costs through centralization and standardization of iv.admixture program[J].Am J Health Syst Pharm,2000,57(12):1147. 被引量:1
6Bates DW,Cullen D,Laird N,et al.Incidence of adverse drug events and potential adverse drug events[J].Jama,1995,274:29. 被引量:1